NIBEC Co., Ltd. (KOSDAQ:138610)
12,620
-250 (-1.94%)
At close: Nov 16, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 143.47 billion as of November 16, 2026. It is the 24,375th most valuable company in the world and the 970th biggest in South Korea. Its market cap has decreased by 68.19% in one year.
Market Cap
143.47B
Enterprise Value
130.86B
Revenue
22.60B
Global Rank
Country Rank
#970 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 143.47B, an increase of 283.26%. That is a compound annual growth rate of 9.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 140.06B | -67.17% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 184.47B |
| HansBiomed | 172.56B |
| curacle co.,ltd. | 168.61B |
| AriBioLab | 162.76B |
| Kangstem Biotech | 161.02B |
| Genome & Company | 155.07B |
| ISU Abxis | 125.99B |
| Y-Biologics | 123.09B |